(February 3, 2017, 9:58 AM EST) -- CLEVELAND — An Ohio federal jury on Feb. 2 returned a defense verdict for Abbott Laboratories Inc. and spinoff AbbVie Inc. in a Depakote birth defect trial (Z.H., et al. v....
Defense Verdict Returned By Ohio Federal Jury In Depakote Birth Defect Trial
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login